Honokiol Ameliorates Post-Myocardial Infarction Heart Failure Through Ucp3-Mediated Reactive Oxygen Species Inhibition

• Main Authors: Jianyu Liu (Author), Minghai Tang (Author), Tao Li (Author), Zhengying Su (Author), Zejiang Zhu (Author), Caixia Dou (Author), Yan Liu (Author), Heying Pei (Author), Jianhong Yang (Author), Haoyu Ye (Author), Lijuan Chen (Author)
• Format: Book
• Published: Frontiers Media S.A., 2022-02-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Post-myocardial infarction heart failure (post-MI HF) is one of the leading global causes of death, and current prevention and treatment methods still cannot avoid the increasing incidence. Honokiol (HK) has previously been reported to improve myocardial ischemia/reperfusion injury and reverse myoca...